Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.59 |
| ▸ | RAB9A | P51151 | 8/20 | 0.59 |
| ▸ | NPC1 | O15118 | 7/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.59 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.59 |
| ▸ | PKM | P14618 | 4/20 | 0.59 |
| ▸ | HPGD | P15428 | 4/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.59 |
| ▸ | TP53 | P04637 | 3/20 | 0.59 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.59 |
| ▸ | TSHR | P16473 | 1/20 | 0.59 |
| ▸ | AR | P10275 | 5/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.50 |
| ▸ | NISCH | Q9Y2I1 | 2/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | MTOR | P42345 | 1/20 | 0.50 |
| ▸ | ADK | P55263 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31241273 | 0.93 | RAB9A (0.53) | ALDH1A1RAB9ANPC1KDM4EHSD17B10 | |
| SCHEMBL28946289 | 0.80 | ADORA3 (0.60) | ALDH1A1RAB9ANPC1KDM4EHSD17B10 | |
| SCHEMBL197279 | 0.78 | NISCH (0.54) | ALDH1A1KDM4ESMN1; SMN2TP53ALOX15 | |
| SCHEMBL12075533 | 0.77 | CCR1 (0.53) | ALDH1A1KDM4ESMN1; SMN2TP53ALOX15 | |
| SCHEMBL14919456 | 0.76 | RAB9A (0.53) | ALDH1A1RAB9ANPC1KDM4EHSD17B10 | |
| Hydrochloric Acid SCHEMBL10653147 | 0.75 | RAB9A (0.65) | ALDH1A1RAB9ANPC1KDM4EHSD17B10 | |
| Hydrochloric Acid SCHEMBL2415958 | 0.75 | RAB9A (0.65) | ALDH1A1RAB9ANPC1KDM4EHSD17B10 | |
| SCHEMBL7125744 | 0.75 | RAB9A (0.44) | ALDH1A1RAB9ANPC1KDM4EHSD17B10 | |
| SCHEMBL8345707 | 0.75 | METAP2 (0.47) | ALDH1A1RAB9ANPC1KDM4EHSD17B10 | |
| SCHEMBL29374931 | 0.75 | RAB9A (0.64) | ALDH1A1RAB9ANPC1KDM4EHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119684261-A | Quinolinyl imidazoles Pb2+Preparation method and application of fluorescent probe | 南京林业大学 | 2025-03-25 | — | — | CN | claimed |
| US-20250082652-A1 | SIGNALLING-PATHWAY INHIBITOR COMBINATIONS FOR USE IN THE TREATMENT OF CANCER DISEASES | UNIVERSITÄT ZU KÖLN (DE) | 2025-03-13 | — | — | US | claimed |
| EP-4460301-A1 | SIGNALLING-PATHWAY INHIBITOR COMBINATIONS FOR USE IN THE TREATMENT OF CANCER DISEASES | Universität zu Köln (DE) | 2024-11-13 | — | — | EP | claimed |
| CN-118745167-A | Preparation method and application of quinolinyl imidazole boron trifluoride fluorescent probe | 南京林业大学 | 2024-10-08 | — | — | CN | claimed |
| EP-3720493-B1 | COMBINATIONS OF RIPK1- AND IKK-INHIBITORS FOR THE PREVENTION OR TREATMENT OF IMMUNE DISEASES | UNIV KOELN (DE) | 2024-07-24 | — | — | EP | claimed |
| WO-2023131576-A1 | SIGNALLING-PATHWAY INHIBITOR COMBINATIONS FOR USE IN THE TREATMENT OF CANCER DISEASES | UNIVERSITÄT ZU KÖLN (DE) | 2023-07-13 | — | — | WO | claimed |
| EP-4209213-A1 | SIGNALLING-PATHWAY INHIBITOR COMBINATIONS FOR USE IN THE TREATMENT OF CANCER DISEASES | Universität zu Köln (DE) | 2023-07-12 | — | — | EP | claimed |
| CN-112174962-A | Synthesis method of benzo [ e ] pyridylimidazo [4,5-g ] isoindole-1, 3(2H) -diketone compound | 河南师范大学 | 2021-01-05 | — | — | CN | claimed |
| CN-119684261-B | Quinolinyl imidazoles Pb2+Preparation method and application of fluorescent probe | 南京林业大学 | 2025-10-28 | — | — | CN | disclosed |
| CN-118745167-B | Preparation method and application of quinolinyl imidazole boron trifluoride fluorescent probe | 南京林业大学 | 2025-10-28 | — | — | CN | disclosed |
| CN-120058749-A | OLED light-emitting layer guest material based on D-A type nitrogen-containing heterocyclic gallium compound and application thereof | 北京师范大学 | 2025-05-30 | — | — | CN | disclosed |
| CN-116473077-B | Synthesis and application of N, N coordinated gallium complex antibacterial agent | 广东方中高新材料有限公司 | 2025-04-11 | — | — | CN | disclosed |
| CN-119684261-A | Quinolinyl imidazoles Pb2+Preparation method and application of fluorescent probe | 南京林业大学 | 2025-03-25 | — | — | CN | disclosed |
| CN-119684261-A | Quinolinyl imidazoles Pb2+Preparation method and application of fluorescent probe | 南京林业大学 | 2025-03-25 | — | — | CN | disclosed |
| EP-1534074-A2 | COMBINATION THERAPY FOR THE TREATMENT OF OBESITY | Merck & Co., Inc. (US) | 2005-06-01 | — | — | EP | disclosed |
| WO-2005000217-A2 | COMBINATION THERAPY FOR THE TREATMENT OF DYSLIPIDEMIA | MERCK & CO., INC. (US) | 2005-01-06 | — | — | WO | disclosed |
| WO-2004110375-A2 | COMBINATION THERAPY FOR THE TREATMENT OF DIABETES | MERCK & CO., INC. (US) | 2004-12-23 | — | — | WO | disclosed |
| WO-2004110368-A2 | COMBINATION THERAPY FOR THE TREATMENT OF HYPERTENSION | MERCK & CO., INC. (US) | 2004-12-23 | — | — | WO | disclosed |
| WO-2004009015-A2 | COMBINATION THERAPY FOR THE TREATMENT OF OBESITY | MERCK & CO., INC. (US) | 2004-01-29 | — | — | WO | disclosed |
| CN-88102448-A | NOVEL NITROGENOUS COMPOUND | — | 1988-11-16 | — | — | CN | disclosed |